Keyphrases
Young Smokers
68%
Tobacco
50%
Minnesota
50%
Lung
50%
Adult Smokers
50%
Health Model
50%
Carcinogen
50%
Cigarettes Smoked per Day
50%
Cigarette Reduction
50%
End of Treatment
50%
Exposure Biomarkers
31%
Carcinogen Exposure
31%
No Significant Difference
31%
Placebo-controlled
25%
Group Effect
25%
Unable or Unwilling
25%
Interaction Effect
25%
Treatment Methods
25%
High Prevalence
25%
Treatment Group
25%
3-month Follow-up
25%
Nicotine Patch
25%
Group Visits
25%
Cigarette Smoking
25%
Comorbidity
25%
Group Interaction
25%
Nicotine Gum
25%
6-month Follow-up
25%
Open-label Trial
25%
Treatment Effect
25%
Cotinine
18%
State Innovation Model
17%
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone
12%
Human Services
10%
Self-evaluation
7%
Health Departments
7%
Medicaid
7%
Medicare
7%
Glucuronide
6%
Nicotine Exposure
6%
Nicotine
6%
History Data
6%
Biomarker Data
6%
Smoking Biomarker
6%
Smoking History
6%
Two-sample
6%
Nursing and Health Professions
Cigarette Filter
100%
Adolescent
70%
Carcinogen
66%
Biological Marker
45%
Cotinine
18%
Prevalence
16%
Placebo
16%
Nicotine Gum
16%
Open-Label Trial
16%
Nicotine Patch
16%
Comorbidity
16%
Treatment Group
16%
4 (Methylnitrosamino) 1 (3 Pyridyl) 1 Butanol
6%
Glucuronide
6%
4 (Methylnitrosamino) 1 (3 Pyridyl) 1 Butanone
6%
